BMS-707035
BMS-707035 is a potent orally active HIV-1 integrase strand transfer inhibitor (INSTI) . BMS-707035 has enzyme inhibitory with an IC50 value of 3 nM. BMS-707035 also has weak CYP inhibiton and antiviral activity. BMS-707035 can be used for the research of human immunodeficiency virus-1 (HIV-1) [1].
Product Specifications
CAS Number
729607-74-3
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
HIV; HIV Integrase
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/BMS-707035.html
Purity
99.99
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
FC1=CC=C(C=C1)CNC(C(N=C(N2C)N3S(CCCC3)(=O)=O)=C(C2=O)O)=O
Molecular Formula
C17H19FN4O5S
Molecular Weight
410.42
Precautions
H302, H315, H319, H335
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HIV-1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD8A (Cytotoxic- & Suppressor T-Cell Marker) (UCHT4), 1mg/mL
